Doctor in Biology and tenured professor at the University of Vigo, José Antonio Lamas started the Neurosciences Group in 1997 in the Faculty of Biology. Last year, the group moved their activities to CINBIO’s facilities and it is from there that they are currently carrying out their research work.
“The study of genome mobility in oncogenic processes will revolutionise future diagnosis and treatment of cancer”
José Tubío has been part of the University of Vigo since 2016 and is one of the most important CINBIO researchers. With a background in Bioinformatics and Molecular Biology, he is a member of the International Cancer Genome Consortium and a recipient of an ERC Starting Grant. He currently leads the Mobile Genomics research group from which he coordinates research dealing with how certain sequences of DNA or tumour cells are mobilised and then cause the development of different types of cancer. Along with the Phylogenomics group led by David Posada, they set up the Evogenomics research group that currently has a team of around 20 people. 9 of the members from Evogenomics are part of the Mobile Genomics team. This multidisciplinary group is made up of bioinformaticians, mathematicians, pathologists, which provides a balance between the computational and the molecular biology areas.
Professor José Luis Legido is one of the 9 PIs of the Applied Physics 2 group at CINBIO and is also chairman of the Galician Thermal Peloid Society. Legido is in charge of a line of research focused on monitoring bacteria growth using microcalorimetric techniques, in which the effects of drugs on the bacteria are analysed. As a result of this research he has published eleven scientific articles, one book, three completed theses and one international patent in collaboration with the Vigo Hospital Complex.
We spoke to Africa González to find out first hand what CINBIO is, its potential and what it represents for the field of biomedics regionally, nationally and internationally.